What is Arexvy? US approves first vaccine for RSV after decades of attempts

The US has approved the first vaccine for respiratory syncytial virus (RSV) for people aged 60 and over. On Wednesday the Food and Drug Administration (FDA) approved the use of Arexvy in the country. The vaccine is said to protect older adults against the respiratory virus. Now the Centers for Disease Control and Prevention (CDC) […]